A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis

Conditions:   Hemodialysis-Associated Amyloidosis;   Dialysis Amyloidosis;   Quality of Life Interventions:   Device: Theranova 400;   Device: Elisio-19H Sponsor:   Selayang Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials